Home > Financial Ratios > PAR DRUGS AND CHEMICALS

PAR DRUGS AND CHEMICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for PAR DRUGS AND CHEMICALS
Please provide your vote to see the results

PAR DRUGS AND CHEMICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.559.918.1310.973.91

What is the latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS ?

The latest EV/Core EBITDA ratio of PAR DRUGS AND CHEMICALS is 3.55 based on Mar2025 Standalone results.
Year EV/Core EBITDA
Mar20253.55
Mar20249.91
Mar20238.13
Mar202210.97
Mar20213.91

How is EV/Core EBITDA of PAR DRUGS AND CHEMICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 3.55
-64.18
Mar2024 9.91
21.89
Mar2023 8.13
-25.89
Mar2022 10.97
180.56
Mar2021 3.91 -

Other Financial Ratios of PAR DRUGS AND CHEMICALS


Compare EV/Core EBITDA ratio of peers of PAR DRUGS AND CHEMICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS ₹109.6 Cr 3.1% -2.2% -12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,096.0 Cr -2.4% 3% 9.6% Stock Analytics
DIVIS LABORATORIES ₹176,807.0 Cr -3.3% 3.5% 4.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,718.0 Cr -2% 5% 43.1% Stock Analytics
CIPLA ₹112,971.0 Cr -0% 6.9% -4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,752.0 Cr -0.3% -3.8% 7.3% Stock Analytics


PAR DRUGS AND CHEMICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PAR DRUGS AND CHEMICALS

3.1%

-2.2%

-12.1%

SENSEX

-0.5%

-3.3%

-7.6%


You may also like the below Video Courses